Table 2.

First-line agents for the management of primary ITP5,6,9,22 

First-line agents for the management of primary ITP5,6,9,22

* Variable response rates are reflective of various dosing and definition of response. By 72 hours, ∼ 80%-90% of patients demonstrate a response regardless of dose.

Close Modal

or Create an Account

Close Modal
Close Modal